GSK Canada is pleased to announce that Ojjaara (momelotinib) will now be reimbursed by Régie de l'assurance maladie du Québec ...
According to Diabète Québec, type 2 diabetes is the most common form, affecting nearly 90% of those living with diabetes, and many eventually require insulin when lifestyle changes and oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback